The earlier diseases are diagnosed, the earlier they can be treated. Unfortunately, time is often of the essence for those with rare genetic disorders. For example, the few therapies that exist for ...

The Genomes2People Research Program (G2P), led by Robert Green at Brigham and Women’s Hospital, the Broad Institute, Ariadne Labs, and Harvard Medical School, conducts research to accelerate the ...

PARIS — Will the traditional newborn screening program developed 60 years ago by Dr Robert Guthrie soon be superseded by genome screening at birth? Routine sampling and analysis of newborn DNA would ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

RALEIGH, N.C. - Tiffany King had given birth to her daughter, Fern, a little more than a month earlier and was back at her job as a construction manager when the phone rang. The caller said she had ...

Soon after birth, a baby receives its first diagnostic test—a small heel prick yielding several blood drops analyzed for dozens of inherited conditions. Newborn screening is standard in all states. A ...

San Diego – Dec. 5, 2024 – Two studies published today in the American Journal of Human Genetics show the potential for genomic screening in newborns to address high rates of infant hospitalization ...

Despite advances, whole genome sequencing — and with it the promise of early, life-altering therapies — still isn’t a routine part of care for most newborns. Many babies enter the world with silent ...

WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, ...

SOME time in the next few days a new era in healthcare will be born. Doctors in Boston will sequence the whole genome of a newborn, the first of 240 babies to be fully sequenced. Afterwards, the ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, ...

Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation sequencing ...